
    
      The purpose of this study is to assess bioequivalence after single administration of the
      following 4 types of formulation: normal 10 mg rabeprazole tablet rabeprazole, and Type 1,
      Type 2, and Type 3 granule formulation containing rabeprazole 10 mg.
    
  